TY - JOUR
T1 - Neuroactive steroid and stress response
AU - Nagai, T.
AU - Noda, Y.
AU - Nozaki, A.
AU - Nabeshima, T.
PY - 2001
Y1 - 2001
N2 - Dehydroepiandrosterone sulfate (DHEAS), a neuroactive steroid, has been demonstrated to bind to sigma1 receptors, and it has antidepressive effects in the forced swimming test. We used the conditioned fear stress, which is useful for investigating the pathogenesis of mood disorders. DHEAS attenuated the conditioned fear stress response in mice, the effects being antagonized by a sigma1 receptor antagonist. It is interesting that, the DHEAS contents and number of apoptotic cells in the brain of mice showing conditioned fear stress response were decreased and increased, respectively, compared with those in the nonstressed mice. DHEAS prevented the expression of apoptosis induced by conditioned fear stress. These findings suggest that the imbalance of neuroactive steroids and the expression of apoptosis play an important role in the expression of conditioned fear stress response and that the use of DHEAS is a novel therapeutic approach for at least some mood disorders.
AB - Dehydroepiandrosterone sulfate (DHEAS), a neuroactive steroid, has been demonstrated to bind to sigma1 receptors, and it has antidepressive effects in the forced swimming test. We used the conditioned fear stress, which is useful for investigating the pathogenesis of mood disorders. DHEAS attenuated the conditioned fear stress response in mice, the effects being antagonized by a sigma1 receptor antagonist. It is interesting that, the DHEAS contents and number of apoptotic cells in the brain of mice showing conditioned fear stress response were decreased and increased, respectively, compared with those in the nonstressed mice. DHEAS prevented the expression of apoptosis induced by conditioned fear stress. These findings suggest that the imbalance of neuroactive steroids and the expression of apoptosis play an important role in the expression of conditioned fear stress response and that the use of DHEAS is a novel therapeutic approach for at least some mood disorders.
UR - http://www.scopus.com/inward/record.url?scp=0035679567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035679567&partnerID=8YFLogxK
M3 - Short survey
C2 - 11797418
AN - SCOPUS:0035679567
SN - 1340-2544
VL - 21
SP - 157
EP - 162
JO - Japanese Journal of Psychopharmacology
JF - Japanese Journal of Psychopharmacology
IS - 5
ER -